Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Signe Benzon Larsen"'
Autor:
Signe Benzon Larsen, Christian Dehlendorff, Charlotte Skriver, Anton Pottegård, Søren Friis, Martin Andreas Røder, Klaus Brasso, Anne Katrine Duun-Henriksen
Publikováno v:
Larsen, S B, Dehlendorff, C, Skriver, C, Pottegård, A, Friis, S, Røder, M A, Brasso, K & Duun-Henriksen, A K 2022, ' Prescription rates for commonly used drugs before and after a prostate cancer diagnosis ', Cancer Causes and Control, vol. 33, no. 3, pp. 417-428 . https://doi.org/10.1007/s10552-021-01537-8
Purpose: To investigate differences in prescription rates of commonly used drugs among prostate cancer patients and cancer-free comparisons and between patients diagnosed with localized and non-localized disease. Methods: We conducted a register-base
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::576575574056a079f36c53281eb84fa7
https://portal.findresearcher.sdu.dk/da/publications/88a1a039-57ab-424c-acd3-31668eceb039
https://portal.findresearcher.sdu.dk/da/publications/88a1a039-57ab-424c-acd3-31668eceb039
Autor:
Sandra Miriam Kawa, Martin Andreas Røder, John Thomas Helgstrand, Klaus Brasso, Hein Vincent Stroomberg, Signe Benzon Larsen, Birgitte Grønkær Toft
Publikováno v:
Kawa, S M, Stroomberg, H V, Larsen, S B, Helgstrand, J T, Toft, B G, Brasso, K & Røder, M A 2021, ' Detection of Clinically Significant Prostate Cancer by Systematic TRUS-Biopsies in a Population-Based Setting Over a 20 Year Period ', Urology, vol. 155, pp. 20-25 . https://doi.org/10.1016/j.urology.2021.06.007
Objective: To assess the performance of systematic TRUS-biopsies in a population-based setting to detect clinically significant PCa (csPCa) in combination with age, clinical tumor category (cT), and prostate-specific antigen (PSA) in men referred for
Autor:
Ida Rask Moustsen, Anne Katrine Duun-Henriksen, Klaus Brasso, Anne Sofie Friberg, Susanne K. Kjaer, Susanne Oksbjerg Dalton, Anne Tjønneland, Christoffer Johansen, Signe Benzon Larsen
Publikováno v:
Acta Oncologica. 58:715-721
Background: High socioeconomic position is associated with better prognosis in prostate cancer patients but it is unknown if part of this association may be explained by socioeconomic differences i...
Autor:
Henrik Møller, Susanne Oksbjerg Dalton, Christoffer Johansen, Jeanette Falck Winther, Signe Benzon Larsen, Michael Borre, Pernille Envold Bidstrup, Elisabeth Wreford Andersen, Trille Kristina Kjaer
Publikováno v:
Kjaer, T K, Andersen, E A W, Winther, J F, Bidstrup, P E, Borre, M, Møller, H, Larsen, S B, Johansen, C & Dalton, S O 2019, ' Long-term Somatic Disease Risk in Adult Danish Cancer Survivors ', JAMA Oncology, vol. 5, no. 4, pp. 537-545 . https://doi.org/10.1001/jamaoncol.2018.7192
Importance Long-term health effects of cancer in adult survivors are a major concern; however, it is difficult to differentiate between the consequences of cancer and cancer treatment and those of normal aging or comorbidity. Objectives To provide an
Autor:
Klaus Kaae Andersen, Ingelise Andersen, Caroline Sophie Lerhmann-Lerche, Martin Andreas Røder, Klaus Brasso, Lau Caspar Thygesen, Anne Katrine Duun-Henriksen, Susanne Oksbjerg Dalton, Christoffer Johansen, Signe Benzon Larsen
Publikováno v:
Lerhmann-Lerche, C S, Larsen, S B, Andersen, I, Thygesen, L C, Kaae Andersen, K, Duun-Henriksen, A K, Johansen, C, Røder, M A, Brasso, K & Dalton, S O 2019, ' Educational level and first-time PSA testing in general practice ', Scandinavian Journal of Urology, vol. 53, no. 5, pp. 275-281 . https://doi.org/10.1080/21681805.2019.1681503
Introduction: Different patterns in the use of prostate-specific antigen (PSA) testing might explain socioeconomic differences in prostate cancer incidence and mortality. We examined the association between socioeconomic position, measured as educati
Autor:
Anne Tjønneland, Line Kenborg, Susanne Oksbjerg Dalton, Niels Kroman, Christoffer Johansen, Signe Benzon Larsen, Pernille Envold Bidstrup, Maia Torstensson, Jane Christensen
Publikováno v:
Breast Cancer Research and Treatment. 170:605-612
We investigated whether changes in body mass index (BMI) before a breast cancer diagnosis affected mortality and whether trajectories more accurately predict overall mortality compared to a single measure of BMI. Our prospective cohort comprised 2012
Autor:
Anne Tjønneland, Christian Dehlendorff, Jesper Hallas, Søren Friis, Klaus Brasso, Signe Benzon Larsen, Henrik Toft Sørensen, Anton Pottegård, Michael Borre, Charlotte Skriver
Publikováno v:
Skriver, C, Dehlendorff, C, Borre, M, Brasso, K, Larsen, S B, Tjønneland, A, Pottegård, A, Hallas, J, Sørensen, H T & Friis, S 2020, ' Associations of low-dose aspirin or other NSAID use with prostate cancer risk in the Danish Diet, Cancer and Health Study ', Cancer causes & control : CCC, vol. 31, no. 2, pp. 139-151 . https://doi.org/10.1007/s10552-019-01252-5
Skriver, C, Dehlendorff, C, Borre, M, Brasso, K, Larsen, S B, Tjønneland, A, Pottegård, A, Hallas, J, Sørensen, H T & Friis, S 2020, ' Associations of low-dose aspirin or other NSAID use with prostate cancer risk in the Danish Diet, Cancer and Health Study ', Cancer Causes and Control, vol. 31, no. 2, pp. 139-151 . https://doi.org/10.1007/s10552-019-01252-5
Skriver, C, Dehlendorff, C, Borre, M, Brasso, K, Larsen, S B, Tjønneland, A, Pottegård, A, Hallas, J, Sørensen, H T & Friis, S 2020, ' Associations of low-dose aspirin or other NSAID use with prostate cancer risk in the Danish Diet, Cancer and Health Study ', Cancer Causes and Control, vol. 31, no. 2, pp. 139-151 . https://doi.org/10.1007/s10552-019-01252-5
PURPOSE: Epidemiologic studies suggest that use of aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) may reduce prostate cancer risk. We examined these associations overall and according to clinical and lifestyle parameters.METHODS: We i
Autor:
Mette Nørgaard, Anton Pottegård, Michael Borre, Henrik Toft Sørensen, Charlotte Skriver, Klaus Brasso, Susanne Oksbjerg Dalton, Signe Benzon Larsen, Søren Friis, Jesper Hallas, Christian Dehlendorff
Publikováno v:
Skriver, C, Dehlendorff, C, Borre, M, Brasso, K, Larsen, S B, Dalton, S O, Nørgaard, M, Pottegård, A, Hallas, J, Sørensen, H T & Friis, S 2019, ' Use of low-dose aspirin and mortality after prostate cancer diagnosis : A nationwide cohort study ', Annals of Internal Medicine, vol. 170, no. 7, pp. 443-452 . https://doi.org/10.7326/M17-3085
Skriver, C, Dehlendorff, C, Borre, M, Brasso, K, Larsen, S B, Dalton, S O, Nørgaard, M, Pottegård, A, Hallas, J, Sørensen, H T & Friis, S 2019, ' Use of Low-Dose Aspirin and Mortality After Prostate Cancer Diagnosis : A Nationwide Cohort Study ', Annals of Internal Medicine, vol. 170, no. 7, pp. 443-452 . https://doi.org/10.7326/M17-3085
Skriver, C, Dehlendorff, C, Borre, M, Brasso, K, Larsen, S B, Dalton, S O, Nørgaard, M, Pottegård, A, Hallas, J, Sørensen, H T & Friis, S 2019, ' Use of Low-Dose Aspirin and Mortality After Prostate Cancer Diagnosis : A Nationwide Cohort Study ', Annals of Internal Medicine, vol. 170, no. 7, pp. 443-452 . https://doi.org/10.7326/M17-3085
Background: Recent studies suggest that aspirin use may improve survival in patients with prostate cancer.Objective: To assess the association between postdiagnosis use of low-dose aspirin and prostate cancer mortality.Design: Nationwide cohort study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dca694fbf27323066bf6aebec6d1d71
https://portal.findresearcher.sdu.dk/da/publications/48d7fefa-ee56-41a5-8cf6-e6b163a184f0
https://portal.findresearcher.sdu.dk/da/publications/48d7fefa-ee56-41a5-8cf6-e6b163a184f0
Autor:
Tim J. Hartung, Anne Tjønneland, Elisabeth Wreford Andersen, Klaus Brasso, Susanne K. Kjaer, Ida Rask Moustsen, Anne Sofie Friberg, Christoffer Johansen, Signe Benzon Larsen, Maja Halgren Olsen, Susanne Oksbjerg Dalton
Publikováno v:
Acta oncologica (Stockholm, Sweden). 58(5)
Background: The risk of depression is inversely associated with socioeconomic position in the general population; however, studies on the association in cancer populations are limited. The aim was ...
Autor:
Klaus Brasso, Søren Friis, Michael Borre, Henrik Toft Sørensen, Charlotte Skriver, Christian Dehlendorff, Jesper Hallas, Anne Tjønneland, Signe Benzon Larsen
Publikováno v:
Skriver, C, Dehlendorff, C, Borre, M, Brasso, K, Sørensen, H T, Hallas, J, Larsen, S B, Tjønneland, A & Friis, S 2016, ' Low-dose aspirin or other nonsteroidal anti-inflammatory drug use and prostate cancer risk : a nationwide study ', Cancer Causes & Control, vol. 27, no. 9, pp. 1067-79 . https://doi.org/10.1007/s10552-016-0785-7
Skriver, C, Dehlendorff, C, Borre, M, Brasso, K, Sørensen, H T, Hallas, J, Larsen, S B, Tjønneland, A & Friis, S 2016, ' Low-dose aspirin or other nonsteroidal anti-inflammatory drug use and prostate cancer risk : a nationwide study ', Cancer Causes & Control, vol. 27, no. 9, pp. 1067–1079 . https://doi.org/10.1007/s10552-016-0785-7
Skriver, C, Dehlendorff, C, Borre, M, Brasso, K, Sørensen, H T, Hallas, J, Larsen, S B, Tjønneland, A & Friis, S 2016, ' Low-dose aspirin or other nonsteroidal anti-inflammatory drug use and prostate cancer risk : a nationwide study ', Cancer Causes & Control, vol. 27, no. 9, pp. 1067–1079 . https://doi.org/10.1007/s10552-016-0785-7
PURPOSE: Increasing evidence suggests that aspirin use may protect against prostate cancer. In a nationwide case-control study, using Danish high-quality registry data, we evaluated the association between the use of low-dose aspirin or other nonster